NCT05506735|Completed
The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History
PSA
Loading search results
PSA
Sponsor study identifier
observational
215
1 country
1
Study Start
May 1, 2022
Actual (reported)Primary Completion
August 17, 2022
Actual (reported)Study Completion
August 17, 2022
Actual (reported)The seven sweeps is a recommended act performed by men after urinating in order to be confident that no urine is left in the urethra, and its not compulsory to perform. It is performed by the following way: after urinating, the anus is first purified if it has become impure; then, the middle finger of the left hand is slid three times from the anus up to the scrotum; then, the thumb is placed on the penis and the forefinger is placed under the penis, and the thumb and forefinger are pulled three times along the penis up to the point of circumcision; finally, the end of the penis is pressed three times.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 17, 2022
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2022
Actual (reported)August 17, 2022
Actual (reported)August 17, 2022
Actual (reported)August 17, 2022
Actual (reported)August 18, 2022
Actual (reported)Prostate specific antigen
PSA is a protein made by the prostate gland. The amount of PSA may be higher in men who have prostate cancer, benign prostatic hyperplasia (BPH), or infection or inflammation of the prostate. Also called prostate-specific antigen test.
30 minutes
Prostate ultrasound
30 minutes
We included 350 participants and 135 if them were excluded. Only 215 who full-filled the criteria were included.
Al-Dar medical Center
Nasiriyah, Thi Qar, 64001, Iraq
Hashim Talib T Hashim, MBChB
University of Baghdad, College of Medicine
215 participants (actual enrollment reported by the registry).
First Submitted
August 17, 2022
First Posted
August 18, 2022
Study Start
May 1, 2022
Actual (reported)Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Contact the study team to confirm eligibility.
Primary Completion
August 17, 2022
Actual (reported)Study Completion
August 17, 2022
Actual (reported)Last Updated
August 19, 2022
Record last verified: 2022-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: